High mitochondria content is associated with prostate cancer disease progression

Table 4 Multivariate analysis including MTC02 expression status in (A) all cancers, (B) ERG negative and (C) ERG positive prostate cancers

A
Scenario (n)	preoperative PSA-level	pT stage	cT stage	Gleason grade prostatectomy	Biopsy gleason grade	N status	R status	MTC02 expression
1 (4,433)	< 0.0001	< 0.0001		< 0.0001		< 0.0001	< 0.0001	0.656
2 (7,226)	< 0.0001	< 0.0001		< 0.0001			< 0.0001	0.8726
3 (7,078)	< 0.0001		< 0.0001	< 0.0001				0.1282
4 (6,974)	< 0.0001		< 0.0001		< 0.0001			0.0007
B
1 (2,220)	0.0026	< 0.0001		< 0.0001		< 0.0001	0.0063	0.7664
2 (3,528)	< 0.0001	< 0.0001		< 0.0001			0.0002	0.8366
3 (3,489)	< 0.0001		< 0.0001	< 0.0001				0.7614
4 (3,442)	< 0.0001		< 0.0001		< 0.0001			0.0384
C
1 (1,791)	0.0117	< 0.0001		< 0.0001		0.0118	0.003	0.7873
2 (2,884)	0.0002	< 0.0001		< 0.0001			< 0.0001	0.8902
3 (2,798)	< 0.0001		< 0.0001	< 0.0001				0.2321
4 (2,752)	< 0.0001		< 0.0001		< 0.0001			0.3955

ISSN: 1476-4598